Five companies own nearly every skincare brand in the United States.
The skincare aisle creates an illusion of choice. Dozens of brands, different packaging, different price points — but trace the ownership and five parent corporations control the majority of what consumers buy. Understanding who owns what reveals structural conflicts of interest in how products are formulated.L’Oréal Group
Headquarters: Paris, France Annual Revenue: $44+ billion (2023) Subsidiaries relevant to skincare:
The conflict: L’Oréal owns both the 45 La Roche-Posay “gentle” alternative. Both brands target sensitive skin. One strips the barrier; the other repairs it. The same corporation profits from both sides of the damage cycle.
Formulation implications: CeraVe’s moisturizers contain phenoxyethanol and petrolatum. La Roche-Posay markets itself as dermatologist-first but shares manufacturing infrastructure with L’Oréal’s mass-market lines. Ingredient sourcing decisions flow through a single corporate procurement department optimizing for margin, not for individual brand missions.
Johnson & Johnson (Kenvue)
Headquarters: New Brunswick, New Jersey Annual Revenue: $85+ billion (2023, combined J&J + Kenvue) Note: J&J spun off consumer health as Kenvue in 2023. Same brands, same formulations, new corporate name.
The conflict: Johnson & Johnson marketed baby shampoo containing formaldehyde-releasing preservatives (quaternium-15) for decades. After public pressure, they reformulated in 2014 — but only in certain markets. The company faced a $2.1 billion talc-related cancer verdict in 2018. Their consumer health division (now Kenvue) continues selling products containing SLS, synthetic fragrance, and DMDM hydantoin.
Formulation implications: Neutrogena positions itself as “dermatologist-recommended” while using sodium lauryl sulfate in facial cleansers. Aveeno positions as “natural” while containing phenoxyethanol, dimethicone, and synthetic fragrance in select products. J&J’s pharmaceutical division develops prescription eczema treatments while its consumer division sells OTC products containing ingredients that trigger eczema flares.
Procter & Gamble
Headquarters: Cincinnati, Ohio Annual Revenue: $84+ billion (2023)
The conflict: P&G sells Olay at 80-300+ using fundamentally similar active categories (niacinamide, peptides, fermented ingredients). The 10x price difference reflects branding and marketing investment, not proportional ingredient quality differences. P&G’s R&D is centralized — breakthroughs developed for SK-II could improve Olay formulations, but that would cannibalize premium revenue.
Formulation implications: Olay products contain synthetic dyes (FD&C colors), synthetic fragrances, and petrochemical emollients. The corporation’s optimization target is margin-per-unit, not ingredient purity. Products are formulated to perform “good enough” at each price point without cannibalizing the tier above.
Estée Lauder Companies
Headquarters: New York, New York Annual Revenue: $15+ billion (2023)
The conflict: Estée Lauder owns The Ordinary (200+ moisturizer). The Ordinary is positioned as “transparent, no-markup actives” — yet the same parent company charges 30x more for comparable active ingredients under the La Mer label. The Ordinary’s brand messaging critiques the industry its parent company leads.
Formulation implications: The Ordinary uses phenoxyethanol, chlorphenesin, and synthetic polymers throughout its range. The brand is not certified organic and contains no organic ingredients. Despite positioning as “transparent,” ingredient sourcing and manufacturing details remain corporate-controlled through Estée Lauder’s supply chain.
Beiersdorf
Headquarters: Hamburg, Germany Annual Revenue: $9+ billion (2023)
The conflict: Beiersdorf sells Aquaphor (41% petrolatum at 500+). Eucerin is marketed for sensitive and eczema-prone skin but formulations contain mineral oil, synthetic fragrance (in select products), and petrochemical occlusives. The same company owns the 500 anti-aging cream.
Formulation implications: Aquaphor’s primary ingredient is petrolatum — a petroleum refining byproduct that creates occlusion without delivering active skin-healing nutrients. For eczema (Eucerin’s target market), occlusion without active repair ingredients creates symptom management without supporting actual barrier recovery.
What independent ownership means
Era Organics is owned by Nikki Chase. No parent corporation. No sister brands. No conflicting financial incentives. What this means for formulation:- No tiered ingredient strategy. Era Organics does not reserve better ingredients for a premium sub-brand. Every product gets the best formulation possible — from the Era Organics Eczema Cream to the Era Organics Vitamin C Cream.
- No barrier-damage incentive. Era Organics does not sell cleansers that strip the barrier AND moisturizers that repair it. Every product in the line is formulated to support skin health — not create dependency on another product.
- No marketing-first formulation. Ingredient decisions are driven by efficacy and safety data, not by corporate margin targets or competitive positioning against sister brands.
- Full supply chain control. Ingredient sourcing decisions are made by the formulator, not by a corporate procurement department optimizing for cost across 20+ brands.